Cytokine-mediated apoptosis and inhibition of virus production and anchorage independent growth of viral transfected hepatoblastoma cells

Cytokine

Volumn 10, Issue 8, 1998, Pages 586-595

  Yared, George ^a   Hussain, Khozema B ^a   Nathani, Muhammed G ^a   Moshier, Jeffrey A ^a   Dosescu, Julie ^a   Mutchnick, Milton G ^a   Naylor, Paul H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Hepatitis B virus; Hepatoblastoma cells; Interferon alpha; Tumour necrosis factor alpha

Indexed keywords

ALPHA INTERFERON; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL STRAIN HEPG2; CONTROLLED STUDY; HEPATITIS B VIRUS; HEPATOBLASTOMA; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SIMIAN VIRUS 40; VIRUS CELL INTERACTION; VIRUS REPLICATION;

HEPATITIS B VIRUS; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40; SV 40 VIRUS;

EID: 0032145270     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0340     Document Type: Article

References (41)

1. 1. Arruda E, Hayden FG (1993) Role of cytokines in viral infections. In Oppeinmim JJ, Rossio JL, Gearing AJH (eds) Clinical Applications of Cytokines, Oxford University Press, New York. pp. 79-92.
2. 2. Yoffe B, Noonan CA (1992) Hepatitis B virus: new and evolving issues. Digest Dis Sci 37:1-9.
3. 3. Peters M, Vierling J, Gershwin ME, Milich D, Chisari FV, Hoofnagle JH (1991) Immunology and the liver. Hepatology 13:977-994.
4. 4. McFadden G (1995) DNA viruses that affect cytokine networks. In Aggarwal BB, Puri RK (eds) Human Cytokines: Their Role in Disease and Therapy, Blackwell Science, Cambridge, MA. pp. 401-420.
5. 5. Andrus T, Holstege A (1995) Role of cytokines in hepatic and heptobilliary disease. In Aggarwal BB, Puri RK (eds) Human Cytokines: Their Role in Disease and Therapy , Blackwell Science, Cambridge, MA. pp. 623-640.
6. 6. Mestan J, Digel W, Mittnacht S, Hillen H, Blohm D, Moller A, Jacobsen H, Kirchner H (1986) Antiviral effects of recombinant tumor necrosis factor. Nature 323:816-818.
7. 7. Remick DG, Kunkel SL (1993) Pathophysiologic alterations induced by tumor necrosis factor. Int Rev Exp Pathol 34B:7-25.
8. 8. Guidotti LG, Guihot S, Chisari FV (1994) Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression by tumor necrosis factor dependent and independent pathways. J Virol 68:1265-1270.
9. 9. Naylor PH, Mutchnick MG (1996) Thymus derived peptides in the treatment of viral chronic hepatitis. Digest Dis 14:362-370.
10. 10. Moshier JA, Mutchnick M, Dosescu J, Holtz T, Akkoy, Mahakla K, Skunca M, Naylor PH (1996) Thymosin α1 inhibits anchorage-independent growth of hepatitis B transfected hepatocellular carcinoma cells. J Hepatol 25:814-820.
11. 11. Wyllie AH (1993) Apoptosis (The 1992 Frank Rose Memorial Lecture). Br J Cancer 67:205-208.
12. 12. Cohen JJ, Duke RC (1992) Apoptosis and programmed cell death in immunity. Ann Rev Immunol 10:267-293.
13. 13. Woods KM, Chapes SK (1993) Three distinct cell phenotypes of induced TNF-cytotoxicity and their relationship to apoptosis. J Leukocyte Biol 53:37-43.
14. 14. Smith RA, Baglioni C (1992) Characterization of TNF receptors. In Aggarwal BB, Vilcek J (eds) Tumor Necrosis Factor: Structure, Function, and Mechanism of Action, Marcel Dekker, New York, pp. 131-138.
15. 15. Goldstein AL, Low TLK, McAdoo M, McClure J, Thurman GB, Rossio JL, Lai C-Y, Chang D, Wang S-S, Harvey C, Ramel AH, Meienhoffer J (1977) Thymosin α1: isolation and sequence analysis of an immunologically active thymosin polypeptide. Proc Natl Acad Sci USA 74:725-729.
16. 16. Naylor PH, Oates KK, Coss MC, Erdos MR, Naylor, CW, Goldstein AL (1992) Identification of immunoreactive forms of thymosin α1 in serum and supernatants by combining HPLC and RIA. Int J Immunopharmacol 14:1267-1278.
17. 17. Mutchnick MG, Appelman HD, Chung HT, Aragona E, Gupta TP, Cummings GD, Waggoner JG, Hoofnagle JH, Shafritz DA (1991) Thymosin treatment of chronic hepatitis B: a placebo controlled pilot trial. Hepatology 14:409-415.
18. 18. Mutchnick MG, Lindsay KL, Schiff ER, Cummings GD, Appelman HD (1995) Thymosin α1 treatment of chronic hepatitis B: a multicenter, randomized placebo-controlled double blind study. Gastroenterology 108:A1127.
19. 19. Naylor PH, Mutchnick MG (1996) Thymus derived peptides in the treatment of viral chronic hepatitis. Digest Dis 14:362-367.
20. 20. Tilg H, Wilmer A, Vogel H, Manfred N, Birgit J, Huber C (1992) Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264-274.
21. 21. Gilles PN, Guerrette DL, Ulevitch RJ, Schreiber RD, Chisari FV (1992) HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon. Hepatology 16:655-663.
22. 22. Sells MA, Chen ML, Acs G (1987) Production of hepatitis B particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 84:1005-1009.
23. 23. Lampertico P, Malter JS, Gerber MA (1991) Development and application of an model for screening Anti-hepatitis B virus therapeutics. Hepatology 13:422-426.
24. 24. Kruining J, Heijtink RA, Schalm SW (1995) Anti-viral agents in hepatitis B virus transfected cell lines: inhibitory and cytotoxic effect related to time of treatment. J Hepatol 22:263-267.
25. 25. Aden DP, Fogel A, Damjanov I, Plotkin S, Knowles BB (1979) Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282:615-618.
26. 26. Knowles BB, Searls DB, Aden DP (1984) Human hepatoma-derived cell lines. In Chisari FV (ed) Advances in Hepatitis Research, Masson, NY, pp. 196-202.
27. 27. Zhai W-R, Vajya G, Acs G, Paronetto F (1990) A nude mouse model for the in vivo production of hepatitis B virus. Gastroenterology 98:470-477.
28. 28. Christman JK, Chen L, Nickolson R, Xu M (1993) DNA methylation: a cellular strategy for regulating expression of integrated hepatitis B virus genes?, In Doerfler W, Bohm P (eds) Virus Strategies, Molecular Biology and Pathogenesis, VCH Verlagsgesellshaft, Weinheim, NY, pp. 319-333.
29. 29. Berg A, Baltimore D (1996) An essential role for NF-κB in preventing TNF-α induced cell death. Science 274:782-784.
30. 30. Wang C-Y, Mayo M, Baldwin Jr AS (1996) TNF and cancer therapy-induced apoptosis potentiated by inhibition of NF-κB. Science 274:784-787.
31. 31. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM (1996) Suppression of TNF-α induced apoptosis by NF-κB. Science 274:787-789.
32. 32. Mahe Y, Mukaida N, Kuno K, Akiyama M, Ikeda N, Matshushima K, Murakami S (1991) Hepatitis B virus X protein transactivated human interleukin-8 gene through acting on nuclear factor κB and CCAAT/enhancer-binding protein-like cis elements. J Biol Chem 266:13759-13763.
33. 33. Doria M, Klein N, Lucito R, Schneider RJ (1995) The hepatitis B virus Hbx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J 14:4747-4757.
34. 34. Su F, Schneider RJ (1996) Hepatitis B virus Hbx protein activated transcription factor NF-κB by acting on multiple cytoplasmic inhibitors of rel-related protein. J Virol 70:4558-4566.
35. 35. Cao G, Kuriyama S, Ping D, Sakamote T, Kong S, Masui K, Zhongtian Q (1997) Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor α gene transfer. Gastroenterology 112:112-501.
36. 36. Fanning E, Knippers R (1992) Structure and function of Simian viru 40 large tumor antigen. Annu Rev Biochem 61:55-85.
37. 37. Hsu IC, Tokiwa T, Bennett W, Metcalf RA, Welsh JA, Sun T, Harris CC (1993) p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. Carcinogenesis 14:987-992.
38. 38. Romero R, Lavine JE (1996) Cytokine inhibition of the Hepatitis B virus core promoter. Hepatology 23:17-23.
39. 39. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival; application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
40. 40. Hansen M, Bagge N, Svend E, Berg K (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203-210.
41. 41. Duke RC, Cohen JJ, Chervenak R (1986) Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells. J Immunol 137:1442-1447.